UE
WST icon

Unisphere Establishment’s West Pharmaceutical WST Stock Holding History

Unisphere Establishment’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$7.39M Hold
29,500
– – 0.06% 45
2025
Q4 		$8.12M Hold
29,500
– – 0.06% 49
2025
Q3 		$7.74M Hold
29,500
– – 0.06% 50
2025
Q2 		$6.45M Hold
29,500
– – 0.05% 55
2025
Q1 		$6.6M Buy
29,500
+9,700
+49% +$2.67M 0.06% 54
2024
Q4 		$6.49M Buy
+19,800
New +$6.23M 0.06% 55

Other funds holding WST

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $11.2B AUM 0.58% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Unisphere Establishment's WST Position: Q1 2026 in Review

Unisphere Establishment held its West Pharmaceutical (WST) position steady in Q1 2026 at 29,500 shares worth $7.39M. The position accounts for 0.06% of the portfolio, ranked #45.

Unisphere Establishment first reported a position in WST in Q4 2024 and has held it in 6 quarters since. The position peaked at $8.12M in Q4 2025. 753 funds tracked by Wall St. Rank hold WST as of Q1 2026.

  • Unisphere Establishment held 29,500 shares of West Pharmaceutical worth $7.39M as of Q1 2026.
  • Unisphere Establishment left its West Pharmaceutical share count unchanged in Q1 2026.
  • West Pharmaceutical made up 0.06% of Unisphere Establishment's portfolio in Q1 2026, its #45 holding.
  • Unisphere Establishment first reported a position in West Pharmaceutical in Q4 2024 and has held it in 6 quarters since.
  • Unisphere Establishment's West Pharmaceutical position peaked at $8.12M in Q4 2025.
  • 753 funds tracked by Wall St. Rank held West Pharmaceutical as of Q1 2026.

Based on Unisphere Establishment's 13F filing for Q1 2026, filed 14 May 2026.